NEWTON, Mass. & WESTON, Mass.--(BUSINESS WIRE)--Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercializing innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan diseases, today announced that the company, together with Health Advances, LLC, will present findings from their health economic study of recurrent kidney stone disease in the United States at the Academy of Managed Care Pharmacy Nexus Conference in National Harbor, MD.
